Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Breast Neoplasms 5008Neoplasms 4199Prostatic Neoplasms 2428Carcinoma, Non-Small-Cell Lung 2265Colorectal Neoplasms 2053Lung Neoplasms 1706Multiple Myeloma 1459Lymphoma 1405Leukemia, Myeloid, Acute 1382Neoplasm Metastasis 1376Melanoma 1270Pancreatic Neoplasms 1200Leukemia 1196Ovarian Neoplasms 1193Lymphoma, Non-Hodgkin 1132Precursor Cell Lymphoblastic Leukemia-Lymphoma 1091Head and Neck Neoplasms 1056Leukemia, Lymphocytic, Chronic, B-Cell 994Lymphoma, Follicular 897Colonic Neoplasms 896Brain Neoplasms 877Stomach Neoplasms 858Recurrence 855Carcinoma, Hepatocellular 846Glioblastoma 842Lymphoma, Large B-Cell, Diffuse 772Rectal Neoplasms 759Uterine Cervical Neoplasms 729Carcinoma, Renal Cell 705Hodgkin Disease 698

Interventions

Laparotomy 1Hyperthermic Intraperitoneal Chemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Interventional × Krukenberg Tumor × Clear all
NCT01226394 2026-04-06

ProphyloCHIP

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed
150 enrolled
Gynecologic

Krukenberg Tumor, Peritoneal Neoplasms

NCT01834469 2014-10-15

OV-AP-ICG-IV

Jules Bordet Institute

Phase 1/2 Completed
10 enrolled
Gynecologic

Krukenberg Tumor, Ovarian Neoplasms, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡